tiprankstipranks
Crescent Biopharma (CBIO)
NASDAQ:CBIO
US Market
CBIO
Crescent Biopharma
RESEARCH TOOLSreports
Want to see CBIO full AI Analyst Report?

Crescent Biopharma (CBIO) Ownership - Who Owns Crescent Biopharma?

1,024 Followers

Crescent Biopharma (CBIO) Ownership Overview

11.26%5.25%48.04%5.80%29.65%
11.26% Insiders
5.25% Mutual Funds
48.04% Other Institutional Investors
5.80% ETFs
29.65% Public Companies and
Individual Investors
The ownership structure of Crescent Biopharma (CBIO) stock is a mix of institutional, retail, and individual investors. Approximately 59.09% of the company’s stock is owned by Institutional Investors, 11.26% is owned by Insiders, and 29.65% is owned by Public Companies and Individual Investors.
The ownership structure of Crescent Biopharma (CBIO) stock is a mix of institutional, retail, and individual investors. Approximately 53.29% of the company’s stock is owned by Institutional Investors, 11.26% is owned by Insiders, and 5.80% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jul 20, 2026
Fairmount Funds Management Llc
xxxxxxxxxxxxx
$12375025
Dec 08, 2025
Fairmount Funds Management Llc
xxxxxxxxxxxxx
$18237600
Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2026
Blackstone Inc.
xxxxxxxxxxxxx
$1127646
Jun 30, 2026
Woodline Partners Lp
xxxxxxxxxxxxx
$1700784
Show More Hedge Fund Trading Activity >

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
3,601,316Insider9.70%64,571,596
Peter Harwin
2,747,866Institution7.40%49,269,237
1,199,274Institution3.23%21,502,983
813,999Institution2.19%14,595,002
780,782Institution2.10%13,999,421
466,381Institution1.26%8,362,211
Richard Driehaus
302,457Institution0.81%5,423,054
281,212Insider0.76%5,042,131
251,090Institution0.68%4,502,044
221,065Institution0.60%3,963,695

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
780,782Institution2.10%13,999,421
466,381Institution1.26%8,362,211
251,090Institution0.68%4,502,044
221,065Institution0.60%3,963,695
113,421Institution0.31%2,033,639
74,714Institution0.20%1,339,622
12,607Institution0.03%226,044
8,300Institution0.02%148,819
8,006Institution0.02%143,548
7,409Institution0.02%132,843

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
Vanguard
906,646Institution2.44%13,119,168
iShares
532,283Institution1.43%9,543,834
iShares
204,350Institution0.55%3,663,996
Vanguard
121,421Institution0.33%1,756,962
Vanguard
83,801Institution0.23%1,212,600
iShares
72,879Institution0.20%1,306,720
Vanguard
62,236Institution0.17%900,555
SPDR
40,180Institution0.11%713,597
Vanguard
23,338Institution0.06%337,701
Virtus
17,503Institution0.05%313,829

FAQ

Who Owns Crescent Biopharma (CBIO)?
According to the latest TipRanks data, approximately 48.04% of the company's stock is held by institutional investors, 11.26% is held by insiders, and 29.65% is held by retail investors.
    What percentage of Crescent Biopharma (CBIO) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 48.04% of Crescent Biopharma (CBIO) stock is held by institutional investors.
      What percentage of Crescent Biopharma (CBIO) stock is held by retail investors?
      According to the latest TipRanks data, approximately 29.65% of Crescent Biopharma (CBIO) stock is held by retail investors.
        Who owns the most shares of Crescent Biopharma (CBIO)?
        Fairmount Funds Management LLC owns the most shares of Crescent Biopharma (CBIO).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.